Yunhao Wu, Xiu Yu, Yuwei Wang, Yalin Huang, Jiahui Tang, Shuaishuai Gong, Siyu Jiang, Yuanli Xia, Fang Li, Boyang Yu, Yuanyuan Zhang, Junping Kou. Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ Acta Pharmaceutica Sinica B 12 (2022) 1198–1212J. Acta Pharmaceutica Sinica B, 2022, 12(7): 3198-3199. DOI: 10.1016/j.apsb.2022.04.004
|
Citation:
|
Yunhao Wu, Xiu Yu, Yuwei Wang, Yalin Huang, Jiahui Tang, Shuaishuai Gong, Siyu Jiang, Yuanli Xia, Fang Li, Boyang Yu, Yuanyuan Zhang, Junping Kou. Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ Acta Pharmaceutica Sinica B 12 (2022) 1198–1212J. Acta Pharmaceutica Sinica B, 2022, 12(7): 3198-3199. DOI: 10.1016/j.apsb.2022.04.004
|
Yunhao Wu, Xiu Yu, Yuwei Wang, Yalin Huang, Jiahui Tang, Shuaishuai Gong, Siyu Jiang, Yuanli Xia, Fang Li, Boyang Yu, Yuanyuan Zhang, Junping Kou. Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ Acta Pharmaceutica Sinica B 12 (2022) 1198–1212J. Acta Pharmaceutica Sinica B, 2022, 12(7): 3198-3199. DOI: 10.1016/j.apsb.2022.04.004
|
Citation:
|
Yunhao Wu, Xiu Yu, Yuwei Wang, Yalin Huang, Jiahui Tang, Shuaishuai Gong, Siyu Jiang, Yuanli Xia, Fang Li, Boyang Yu, Yuanyuan Zhang, Junping Kou. Author correction to ‘Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling’ Acta Pharmaceutica Sinica B 12 (2022) 1198–1212J. Acta Pharmaceutica Sinica B, 2022, 12(7): 3198-3199. DOI: 10.1016/j.apsb.2022.04.004
|
DownLoad: